Owner and operator of a bio pharmaceutical company intended to offer therapeutics for neurologic, metabolic and oncologic diseases. The company bio pharmaceutical services include using proprietary technology for the development of drug products that cross the blood-brain barrier, enabling patients to avail treatment for neurologic, metabolic and oncologic diseases of the brain.
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
3. Out of Business | Completed | Out of Business | ||||
2. Early Stage VC | 01-Jan-2013 | Completed | Startup | |||
1. Accelerator/Incubator | Completed | Startup |
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Michael Dunn | Co-Founder, President and Chief Executive Officer |